-
WAY-100635: Selective 5-HT1A Antagonism
2026-09-26
WAY-100635 is a potent, selective, silent antagonist used in serotonin receptor antagonist research and neuroscience receptor pharmacology. Product information reports nanomolar binding potency and antagonist activity, while the cannabidiol pain study supports a serotonergic research question—not proof that 5-HT1A receptors mediate CBD’s effects.
-
PP2A Links Autophagy to Candida Biofilm Resistance
2026-09-26
A 2025 study links the PP2A catalytic-subunit gene PPH21 to autophagy, biofilm formation, and antifungal resistance in Candida albicans. Its mutant-strain and mouse-infection findings suggest that PP2A-dependent autophagy contributes to reduced antifungal efficacy, although the precise phosphorylation mechanism and its broader clinical relevance need further study.
-
IWP-2 Beyond Assay Control: Translational Wnt Strategy
2026-09-25
IWP-2 offers a way to test whether secreted Wnt ligand production contributes to a phenotype—not simply whether Wnt signaling is present. This article connects its mechanism and preclinical evidence to practical experimental choices, while clarifying what combination studies can and cannot establish.
-
A Live-Cell Fluorescence Probe for HO-1 Activity
2026-09-25
The study introduces AMC-Hem, an aminocoumarin–heme fluorescence probe that enables real-time measurement and imaging of heme oxygenase-1 activity in living primary human macrophages. Its application links HO-1 activity to erythrocyte-containing lysosomes, identifies small-molecule regulation beyond transcription, and demonstrates activity measurement in healthy human serum—findings that support further assay development, not yet clinical use.
-
Carbapenemase Gene Dynamics in Guangdong CREC
2026-09-24
A multicenter study of 54 carbapenem-resistant Enterobacter cloacae isolates combined gene localization, conjugation, mobile-element profiling, and strain fingerprinting to examine how carbapenemase genes may spread. Plasmid-associated blaNDM-1 and frequent transfer in laboratory experiments highlight the value of surveillance that tracks both resistance genes and bacterial lineages.
-
Tigecycline: Mechanism, Evidence, and Research Use
2026-09-24
Tigecycline is a glycylcycline antibiotic and bacteriostatic 30S ribosomal subunit inhibitor with activity against selected resistant bacteria. This article distinguishes product specifications and drug-label evidence from a recent carbapenem-resistant Enterobacter cloacae study, which measured carbapenemase gene transmission but did not test tigecycline susceptibility.
-
FGFR3 Translation with NVP-BGJ398 Phosphate
2026-09-23
NVP-BGJ398 phosphate offers a biomarker-led way to connect FGFR1–3 inhibition with cancer and skeletal disease research. This article examines its mechanism, validation strategy, translational boundaries, and practical workflow for moving from genotype to pathway response and tissue phenotype.
-
Carbapenemase Gene Transmission in CREC, 2022–2024
2026-09-23
This multicenter study mapped carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, combining gene localization, susceptibility testing, conjugation, mobile-element analysis, and clonal typing. Its central finding is that plasmid-associated blaNDM-1 was common and readily transferable, supporting integrated surveillance that distinguishes horizontal gene dissemination from clonal spread.
-
BI-1347 Inhibitor: CDK8 Workflow Guide
2026-09-22
Build a controlled BI-1347 inhibitor workflow for CDK8/19-focused signaling, inflammatory chondrocyte models, transcriptomics, and exploratory antitumor studies. The guide distinguishes product specifications from assay starting conditions and shows how to troubleshoot potency, solubility, and pathway-readout problems.
-
ML365: TASK1 Workflows and Research Applications
2026-09-21
ML365 is a nanomolar TASK1 channel probe for connecting membrane excitability with inflammatory and cognitive phenotypes. Its cross-platform activity supports ion channel pharmacology research, while the aged-mouse postoperative cognitive impairment model provides a practical route to neuroinflammation-focused validation.
-
SAG: Smoothened Receptor Agonist for Hh Research
2026-09-21
SAG is a selective Smoothened receptor agonist that activates Hedgehog signaling and increases pathway readouts such as Gli1 and Ptch1. Preclinical evidence links SAG treatment with mitochondrial and neuroglial improvements in frataxin-deficient astrocyte models, while product data also document developmental and formulation constraints.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflows
2026-09-20
Turn rabbit primary antibodies into measurable fluorescence across immunofluorescence, flow cytometry, and tissue imaging workflows. This guide combines practical assay design, signal-amplification logic, and troubleshooting with a fibrosis-focused research use case inspired by recent IL-11 engineering work.
-
BMS 309403: Practical FABP4 Inhibitor Workflows
2026-09-19
BMS 309403 provides a selective way to connect FABP4 activity with macrophage lipid handling, inflammatory signaling, and foam-cell formation. This workflow-oriented guide covers concentration planning, mechanistic controls, assay readouts, and troubleshooting for atherosclerosis and metabolic disease research.
-
SAG in Neuroglial Disease Modeling: A Causal Guide
2026-09-19
SAG, a selective Smoothened receptor agonist, offers more than routine Hedgehog pathway activation. This guide shows how to use it to distinguish astrocyte-intrinsic mitochondrial rescue from neuron–glia protection while addressing dosing, developmental risk, and assay interpretation.
-
PDX1-Mutant Macaques Reveal m6A Changes in MODY4
2026-09-18
Zhang et al. used CRISPR/Cas9-generated PDX1-mutant cynomolgus macaques to connect pancreatic agenesis and developmental abnormalities with altered m6A methylation. Transcriptomic analysis, islet organoid validation, and METTL3 rescue experiments suggest that epitranscriptomic dysregulation contributes to PDX1-associated diabetes phenotypes, while also illustrating the value and limits of nonhuman primate models.